|
Richard Fulmer’s career spans over thirty years, with twenty-five years spent at Pfizer, Inc., where he served in a number of high-level marketing and business development capacities. Mr. Fulmer retired from Pfizer in 2001 where he was the Vice President and General Manager for the Pfizer Animal Health Division. He also spent over five years as Vice President Licensing and Development for Pfizer.
While at Pfizer, Mr. Fulmer was a key part of the commercial launch of the leading anti-fungal agent Diflucan, the number one selling SSRI antidepressant Zoloft and the novel alpha-blocker Cardura used for benign prostate hypertrophy. He was also responsible for the formation of a strategic alliance with Eisai related to the clinical development and commercialization of Aricept for Alzheimer’s disease, the creation of a co-development and co-promotion agreement with Park Davis for Lipitor, and the licensing and marketing agreement with Pharmacia for its Cox-2 product Celebrex.
Mr. Fulmer received his MBA from George Washington University, School of Government and Business and was selected as a David Rockefeller Fellow by the New York Chamber of Commerce and as Outstanding Man of America, in addition to serving as Captain in the United States Marine Corps. | 